Lori Koch
Director of Finance/CFO chez DUPONT DE NEMOURS, INC.
Fortune : 8 M $ au 31/03/2024
Profil
Actuellement, Lori D. Koch occupe le poste de directeur financier et vice-président exécutif chez DuPont de Nemours, Inc. et de directeur, directeur financier et vice-président exécutif chez Nutrition & Biosciences, Inc. (une filiale de DuPont de Nemours, Inc.). Mme Koch est également membre du conseil d'administration d'Aceto Corp. Mme Koch est titulaire d'un diplôme d'études supérieures et d'un diplôme de premier cycle du Babson College et d'un diplôme de premier cycle de la Pennsylvania State University.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
DUPONT DE NEMOURS, INC.
0,02% | 02/03/2024 | 100 219 ( 0,02% ) | 8 M $ | 31/03/2024 |
Postes actifs de Lori Koch
Sociétés | Poste | Début |
---|---|---|
DUPONT DE NEMOURS, INC. | Director of Finance/CFO | 17/02/2020 |
ACETO CORPORATION | Director/Board Member | 01/12/2019 |
Nutrition & Biosciences, Inc.
Nutrition & Biosciences, Inc. Chemicals: Major DiversifiedProcess Industries Nutrition & Biosciences, Inc. manufactures and distributes food & beverages, dietary supplements, and pharmaceutical products. The company is headquartered in Wilmington, DE. | Director of Finance/CFO | - |
Anciens postes connus de Lori Koch
Sociétés | Poste | Fin |
---|---|---|
E I DU PONT DE NEMOURS AND CO | Director of Finance/CFO | - |
Formation de Lori Koch
Babson College | Graduate Degree |
The Pennsylvania State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
DUPONT DE NEMOURS, INC. | Process Industries |
Entreprise privées | 3 |
---|---|
Actylis Corp.
Actylis Corp. Pharmaceuticals: GenericHealth Technology Actylis Corp. engages in the development, marketing, sale, and distribution of chemical compounds used in the pharmaceutical, nutraceutical, agricultural, coatings, and industrial chemical industries. It operates through the following segments: Human Health, Pharmaceutical Ingredients, and Performance Chemicals. The Human Health segment develops and sells finished dosage form generic drugs and nutraceutical products. The Pharmaceutical Ingredients segment supplies active pharmaceutical ingredients and pharmaceutical intermediates. The Performance Chemicals segment comprises of specialty chemicals and agricultural protection products. The company was founded in 1947 and is headquartered in Port Washington, NY. | Health Technology |
EIDP, Inc.
EIDP, Inc. Chemicals: AgriculturalProcess Industries EIDP, Inc. engages in the provision of science-based products and services. It operates through the Seed and Crop Protection segments. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms around the world. The Crop Protection segment serves the global agricultural input industry with products that protect against weeds, insects and other pests, and disease, and that improve overall crop health both above and below ground via nitrogen management and seed-applied technologies. The company was founded by Eleuthere Irenee du Pont in 1802 and is headquartered in Indianapolis, IN. | Process Industries |
Nutrition & Biosciences, Inc.
Nutrition & Biosciences, Inc. Chemicals: Major DiversifiedProcess Industries Nutrition & Biosciences, Inc. manufactures and distributes food & beverages, dietary supplements, and pharmaceutical products. The company is headquartered in Wilmington, DE. | Process Industries |